Skip to main content
Caplight Logo









OrganoTherapeutics SARL

OrganoTherapeutics SARL

Private
Esch-sur-AlzetteHealthcare & Life Scienceshttps://www.organo-therapeutics.com/

Last Round

VC Round

Jul 1, 2023

Total Funding Raised

$789,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

OrganoTherapeutics SARL is a biotechnology company that develops human patient-specific midbrain organoids for the discovery and development of drug candidates targeting Parkinson's disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

midbrain organoidsParkinson's disease researchdrug discoverydisease modelingorgan-on-a-chippreclinical development3D cell culturephenotype-based screeningin vitro modelsneurodegenerative diseaseAI-based phenotypingassembloidspatient stratificationbiotech servicesPD-KG

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrganoTherapeutics SARL Comparables

Compare OrganoTherapeutics SARL with similar companies based on industry and business-model similarity.

OrganoTherapeutics SARL comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivodyne
84%
Herophilus
82%
Brain Organoid Therapeutics
82%

OrganoTherapeutics SARL Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 1, 2023
GrantMar 1, 2023
AcceleratorOct 15, 2020

OrganoTherapeutics SARL Investors

Notable investors and investment history

OrganoTherapeutics SARL investors
InvestorRounds
European Innovation Council FundGrant
Fit 4 StartAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 17, 2026

    Monthly visitors increased 2190% MoM, reaching 1.3K.

  • Jul 1, 2023

    Completed a VC Round funding round.

OrganoTherapeutics SARL Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OrganoTherapeutics SARL Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OrganoTherapeutics SARL's valuation, stock price, and market status.

Firmographic Details

HeadquartersEsch-sur-Alzette
Employee Range10
Year Founded2019
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?